References
1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. 2020;A Novel Coronavirus from Patients with Pneumonia in China. N Engl J Med 382(8):727–33.
http://doi.org/10.1056/NEJMoa2001017
.
2. World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard [Internet] Geneva (Switzerland): WHO; 2022. [cited 2022 Mar 1]. Available from:
https://covid19.who.int/table
.
3. Korea Disease Control and Prevention Agency. COVID-19 [Internet] Sejong: Ministry of Health and Welfare; 2022. [cited 2022 Mar 1]. Available from:
http://ncov.mohw.go.kr/
.
5. Korea Disease Control and Prevention Agency. COVID-19 vaccines [Internet] Cheongju: Korea Disease Control and Prevention Agency; 2022. [cited 2022 Feb 24]. Available from:
https://ncv.kdca.go.kr/
.
7. 전국한의과대학폐계내과협의회. 코로나바이러스감염증-19 한의지료 지침 제2.1판th ed. 2020. p. 1–13.
8. 사단법인대한한의사협회. 코로나바이러스감염증-19 한의진료 권고안 제2판th ed. 2020. p. 1–52.
11. Lee BY, Lee HJ, Kim JW, Choi HY, Kim YJ, Park JM, et al. 2016;The Efficacy of Shihogayonggolmoryo-tang in Combating Excessive Sweating in Heart Disease Syndrome, Called 心病 in Korean Medicine. J Int Korean Med 37(4):601–8.
https://doi.org/10.22246/jikm.2016.37.4.601
.
13. Nam BH, Lee SW. 2003;Testing the validity of the Korean SF-36 Health Survey. J of the Korean Society of Health Statistics 28(2):3–24.
14. Lee YJ, Sohn SS. 2014;The Difference of Quality of Life on Blood Stasis Using SF-36. J Korean Obstet Gynecol 27(4):15–24.
15. Korea Centers for Disease Control and Prevention. 2020. Guidelines for management on surveillance of adverse events following immunization Cheongju (Korea): Korea Centers for Disease Control and Prevention.
18. Kang SW, Hong SE, Park JW, Kwon SW, Yoon SH, Kim KI, et al. 2021;Safety of Korean Medicine Treatment in Patients Vaccinated with the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19/AZD1222): A Case Series. J Int Korean Med 42(4):590–604.
https://doi.org/10.22246/jikm.2021.42.4.590
.
19. Han JH, Kim DG, Lee JY. 2014;A Case Report of Extensive Limb Swelling in Newborn After Vaccination: Unusual Thigh Swelling After Hepatitis B vaccination. J Int Korean Med 28(1):52–60.
https://doi.org/10.7778/jpkm.2014.28.1.052
.
20. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. 2020;Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 383(27):2603–15.
http://doi.org/10.1056/NEJMoa2034577
.
21. Göbel CH, Heinze A, Karstedt S, Morscheck M, Tashiro L, Cirkel A, et al. 2021;Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun 3(3):1–10.
https://doi.org/10.1093/braincomms/fcab169
.
22. 박인상 . 우천경험요결 1판th ed. 경기도 고양시: 소나무; 2016. p. 82.
23. 이광재 . 사상체질과 임상편람 제2권 2판th ed. 서울: 한미의학; 2010. p. 210–216.
24. 류두저우 . 유도주 상한론강의 1 1판th ed. 경기도 파주시: 물고기숲; 2014. p. 109–113.
26. Kim TG, Park SM, Kang H, Shim BS, Kim SH, Choi SH, et al. 2008;Effect of Baekhasuoyijung-Tang on Mouse T Cell Cytokines. Korean J Oriental Physiology & Pathology 22(4):754–61.
27. Filshie Jacqueline, White Adrian, Cummings Mike. Medical Acupuncture: A Western Scientific Approach 2nd editionth ed. Seoul: HANMI Medical Publishing Co; 2019. p. 40.